AU2002312348A1 - Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them - Google Patents
Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing themInfo
- Publication number
- AU2002312348A1 AU2002312348A1 AU2002312348A AU2002312348A AU2002312348A1 AU 2002312348 A1 AU2002312348 A1 AU 2002312348A1 AU 2002312348 A AU2002312348 A AU 2002312348A AU 2002312348 A AU2002312348 A AU 2002312348A AU 2002312348 A1 AU2002312348 A1 AU 2002312348A1
- Authority
- AU
- Australia
- Prior art keywords
- preparing
- processes
- methods
- pharmaceutical compositions
- peptide gnrh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29581201P | 2001-06-06 | 2001-06-06 | |
US60/295,812 | 2001-06-06 | ||
US30186801P | 2001-06-29 | 2001-06-29 | |
US60/301,868 | 2001-06-29 | ||
PCT/US2002/017846 WO2002098363A2 (en) | 2001-06-06 | 2002-06-05 | NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002312348A1 true AU2002312348A1 (en) | 2002-12-16 |
Family
ID=26969346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002312348A Abandoned AU2002312348A1 (en) | 2001-06-06 | 2002-06-05 | Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1401427A4 (en) |
JP (1) | JP2005501006A (en) |
AU (1) | AU2002312348A1 (en) |
BR (1) | BR0210191A (en) |
CA (1) | CA2449843A1 (en) |
MX (1) | MXPA03011002A (en) |
WO (1) | WO2002098363A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0130341D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
US7205307B2 (en) * | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
MXPA04012566A (en) | 2002-06-13 | 2005-04-19 | Pfizer | Non-peptide gnrh agents, pharmaceutical compositions and methods for their use. |
US7332521B2 (en) * | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
EP1541549A1 (en) | 2003-12-12 | 2005-06-15 | Exonhit Therapeutics S.A. | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods |
WO2008033746A2 (en) * | 2006-09-11 | 2008-03-20 | Curis, Inc. | Tyrosine kinase inhibitors containing a zinc binding moiety |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
CN102329234B (en) * | 2011-06-24 | 2013-11-06 | 灌南伊斯特化工有限公司 | Production process of m-nitrobenzaldehyde |
EP2712862A1 (en) * | 2012-09-28 | 2014-04-02 | Splicos | New anti-invasive compounds |
WO2014184682A1 (en) * | 2013-04-19 | 2014-11-20 | Oslo Universitetssykehus Hf | Radiolabeled gnrh antagonists as pet imaging agents |
CN108905641B (en) * | 2018-08-01 | 2020-04-28 | 湖南七纬科技有限公司 | Nanofiltration membrane and preparation method thereof |
CN114105775A (en) * | 2021-11-30 | 2022-03-01 | 武汉工程大学 | Preparation method of substituted iodobenzene with terminal double bond |
WO2024129600A1 (en) * | 2022-12-13 | 2024-06-20 | Radionetics Oncology, Inc. | Gonadotropin-releasing hormone receptor (gnrhr) targeted therapeutics and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU751139B2 (en) * | 1997-10-13 | 2002-08-08 | Astellas Pharma Inc. | Amide derivative |
KR20010041656A (en) * | 1998-03-05 | 2001-05-25 | 개리 이. 프라이드만 | Non-peptide GnRH Agents |
CZ2001523A3 (en) * | 1998-08-20 | 2002-05-15 | Agouron Pharmaceuticals, Inc. | Non-peptidic GnRH agents, process of their preparation and intermediates for their preparation |
-
2002
- 2002-06-05 CA CA002449843A patent/CA2449843A1/en not_active Abandoned
- 2002-06-05 JP JP2003501405A patent/JP2005501006A/en not_active Withdrawn
- 2002-06-05 MX MXPA03011002A patent/MXPA03011002A/en not_active Application Discontinuation
- 2002-06-05 EP EP02739712A patent/EP1401427A4/en not_active Withdrawn
- 2002-06-05 BR BR0210191-2A patent/BR0210191A/en not_active IP Right Cessation
- 2002-06-05 WO PCT/US2002/017846 patent/WO2002098363A2/en not_active Application Discontinuation
- 2002-06-05 AU AU2002312348A patent/AU2002312348A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA03011002A (en) | 2004-10-28 |
CA2449843A1 (en) | 2002-12-12 |
EP1401427A2 (en) | 2004-03-31 |
BR0210191A (en) | 2004-04-06 |
EP1401427A4 (en) | 2004-12-01 |
JP2005501006A (en) | 2005-01-13 |
WO2002098363A3 (en) | 2003-03-20 |
WO2002098363A2 (en) | 2002-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402560A3 (en) | N-adamantylmethyl derivates, processes for their preparation, pharmaceutical compositions thereof and intermediates | |
MXPA03006775A (en) | Pharmaceutical formulation. | |
MXPA03007641A (en) | Pharmaceutical formulation. | |
HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
AU2002341205A1 (en) | Pharmaceutical compositions comprising cyclosporin | |
AU2002257582A1 (en) | Pharmaceutical formulation | |
AU2002337803A1 (en) | Sustained release pharmaceutical compositions | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AU2002317759A1 (en) | Ophthalmoscope | |
AU2002312348A1 (en) | Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them | |
AU2003233127A1 (en) | Non-peptide gnrh agents, pharmaceutical compositions and methods for their use | |
HUP0401018A3 (en) | 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | |
ZA200402729B (en) | Pharmaceutical formulation comprising (R) -bicalutamide. | |
ZA200404807B (en) | Imidazoquinoline derivatives. | |
AU2002333276A1 (en) | Drugs for vasculopaties | |
IL162497A0 (en) | Benzhydryl derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0401038A3 (en) | Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them | |
AUPR529701A0 (en) | Pharmaceutical composition | |
AU2002365643A1 (en) | Substituted aryl-cycloalkanes, and use thereof as anticancer agents | |
AU2002238748A1 (en) | Pharmaceutical aerosol formulation | |
AU2002361450A1 (en) | Novel pharmaceutical | |
AU2002351637A1 (en) | Compositions, methods and systems for discovery of lipopeptides | |
HUP0401597A3 (en) | Methylene-4-azasteroids, process for their preparation and pharmaceutical compositions containing them | |
ZA200402731B (en) | Pharmaceutical formulation. | |
HUP0402424A3 (en) | Imidazoquinoline derivatives, process for their preparation and pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |